Next-generation EEG Assessment for Neurodegenerative Conditions
Our Vision
We envision a future in which brain health becomes a cornerstone of universal care, transcending its current limitations as specialized care. By democratizing access to groundbreaking neuroimaging technologies, we are enabling the next generation of preventative strategies and innovative treatments.
With a focus on pioneering electroencephalography (EEG) solutions to neurodegeneration, we aim to transform patient care and outcomes in neurology on a global scale.
A new approach to understanding brain health
Mylin, our biomarker platform, is designed to automate EEG analysis to enable quick and rich insights from resting-state data. By analyzing the brain‘s electrical activity, this platform extracts algorithmic biomarkers that streamline the analysis of neurodegeneration. The novel approach provides a direct, user-friendly means to assess brain health and function across a myriad of conditions.
Automate Data Processing
Mylin uses research-grade preprocessing techniques to ensure your data is appropriately cleaned.
Centralize Clinical Analysis
Our cloud-based and highly scalable system can help you centralize data analysis across acquisition sites for studies of any size.
Rapidly Integrate New Workflows
Equipped with our dialogue agent, Mylin can help you effectively integrate new analysis techniques to keep up with the state-of-the-art.
Access Immediate Results
Gain data-driven insights in minutes, not days, and streamline your clinical analysis workflows.
Request a Demo
Ready to see the difference for yourself?